John M. Leonard

Insider Reports History

Entity
Individual
Location
C/O Intellia Therapeutics Inc, 40 Erie Street, Suite 130, Cambridge, MA
Signature
James Basta, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John M. Leonard:

Insider Reports Filed by John M. Leonard

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NTLA Intellia Therapeutics, Inc. Jan 3, 2025 1 -$327K 4 Jan 7, 2025 President and CEO, Director
NTLA Intellia Therapeutics, Inc. Jan 1, 2025 2 $0 4 Jan 3, 2025 President and CEO, Director
IQV IQVIA HOLDINGS INC. May 7, 2024 1 $0 4 May 9, 2024 Director
NTLA Intellia Therapeutics, Inc. Mar 1, 2024 2 $0 4 Mar 5, 2024 President and CEO, Director
NTLA Intellia Therapeutics, Inc. Jan 3, 2024 1 -$566K 4 Jan 5, 2024 President and CEO, Director
NTLA Intellia Therapeutics, Inc. Jan 1, 2024 2 $0 4 Jan 3, 2024 President and CEO, Director
IQV IQVIA HOLDINGS INC. May 10, 2023 1 $0 4 May 12, 2023 Director
NTLA Intellia Therapeutics, Inc. Mar 1, 2023 2 $0 4 Mar 3, 2023 President and CEO, Director
NTLA Intellia Therapeutics, Inc. Jan 4, 2023 1 -$248K 4 Jan 6, 2023 President and CEO, Director
NTLA Intellia Therapeutics, Inc. Jan 1, 2023 2 $0 4 Jan 4, 2023 President and CEO, Director
IQV IQVIA HOLDINGS INC. May 11, 2022 1 $0 4 May 13, 2022 Director
NTLA Intellia Therapeutics, Inc. Jan 1, 2022 5 -$280K 4 Mar 4, 2022 President and CEO, Director
NTLA Intellia Therapeutics, Inc. Aug 30, 2021 21 -$17.4M 4 Sep 1, 2021 President and CEO, Director
NTLA Intellia Therapeutics, Inc. Aug 23, 2021 5 -$3.76M 4 Aug 25, 2021 President and CEO, Director
NTLA Intellia Therapeutics, Inc. Aug 19, 2021 5 -$3.13M 4 Aug 20, 2021 President and CEO, Director